Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар СервьеfiledCriticalЛе Лаборатуар Сервье
Priority to UAA200703875ApriorityCriticalpatent/UA88322C2/en
Publication of UA88322C2publicationCriticalpatent/UA88322C2/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
The present invention relates to the use of agomelatine or N-[2-(7-methoxy-l-naphthyl)ethyl]acetamide for the production of medicaments for use in the treatment of generalized anxiety disorder.
UAA200703875A2007-04-062007-04-06Use of agomelatine for the production of medicaments for use in the treatment of generalized anxiety disorder
UA88322C2
(en)
Crystal form vi of agomelatine; Preparation process; pharmaceutical composition; and its use to treat stress, anxiety, sleep disorders, cardiovascular diseases, schizophrenia, phobia, depression, diseases of the digestive system.
METHOD OF PREPARATION OF CRYSTAL FORMS OF 4-(CYCLOPROPYLMETHOXY)- N-(3,5-DICHLORO-1-OXIDOPYRIDYN-4-yl)-5-METHOXYPYRIDINE-2-CARBOXA MIDE AND CRISTAL FORMS THEREOF.